Effectiveness of fast-track pathway for diabetic foot ulcerations.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 29 03 2021
accepted: 12 04 2021
pubmed: 5 5 2021
medline: 26 11 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

To investigate the effectiveness of fast-track pathway (FTP) in the management of diabetic foot ulceration (DFU) after 2 years of implementation. The study group was composed of patients who referred to a specialized DF centre due to DFUs. Those were divided in two groups: early referral (ER) and late referral (LR) patients. According to FTP, ER were considered patients who referred after 2 weeks in the case of uncomplicated non-healing ulcers (superficial, not infected, not ischemic), within 4 days in the case of complicated ulcers (ischemic, deep, mild infection) and within 24 h in the case of severely complicated ulcers (abscess, wet gangrene, fever). Healing, healing time, minor and major amputation, hospitalization, and survival were evaluated. The follow-up was 6 months. Two hundred patients were recruited. The mean age was 70 ± 13 years, 62.5% were male, 91% were affected by type 2 diabetes with a mean duration of 18 ± 11 years. Within the group, 79.5% had ER while 20.5% had LR. ER patients showed increased rates of healing (89.9 vs. 41.5%, p = 0.001), reduced healing time (10 vs. 16 weeks, p = 0.0002), lower rates of minor (17.6 vs. 75.6%, p < 0.0001) and major amputation (0.6 vs. 36.6%, p < 0.0001), hospitalization (47.1 vs. 82.9%, p = 0.001), and mortality (4.4 vs. 19.5%, p = 0.02) in comparison to LR. At multivariate analysis, ER was an independent predictor of healing, while LR was an independent predictor for minor and major amputation and hospitalization. After the FTP implementation, less cases of LR were reported in comparison to ER. ER was an independent predictor of positive outcomes such as healing, healing time, limb salvage, hospitalization, and survival.

Identifiants

pubmed: 33942178
doi: 10.1007/s00592-021-01721-x
pii: 10.1007/s00592-021-01721-x
pmc: PMC8413149
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1351-1358

Informations de copyright

© 2021. The Author(s).

Références

Manu C, Lacopi E, Bouillet B, Vouillarmet J, Ahluwalia R, Lüdemann C, Garcia-Klepzig JL, Meloni M, De Buruaga VR, Sánchez-Ríos JP, Edmonds M, Apelqvist J, Lázaro-Martínez JL, Van Acker K (2018) Delayed referral of patients with diabetic foot ulcers across Europe: patterns between primary care and specialised units. J Wound Care 27(3):186–192. https://doi.org/10.12968/jowc.2018.27.3.186
doi: 10.12968/jowc.2018.27.3.186 pubmed: 29509115
Garcia-Klepzig JL, Sánchez-Ríos JP, Manu C, Ahluwalia R, Lüdemann C, Meloni M, Lacopi E, De Buruaga VR, Bouillet B, Vouillarmet J, Lázaro-Martínez JL, Van Acker K (2018) Perception of diabetic foot ulcers among general practitioners in four European countries: knowledge, skills and urgency. J Wound Care 27(5):310–319. https://doi.org/10.12968/jowc.2018.27.5.310
doi: 10.12968/jowc.2018.27.5.310 pubmed: 29738299
Meloni M, Izzo V, Manu C, Ahluwalia R, Pedro J, Sánchez-Ríos CL, Vouillarmet J, Garcia-Klepzig JL, De Buruaga VR, Iacopi E, Bouillet B, Guillaumat Jérôme, Martinez Jose Luis Lazaro, Van Acker Kristien (2019) Fast-track pathway: an easy-to-use tool to reduce delayed referral and amputations in diabetic patients with foot ulceration. Diabet Foot J 22(2):38–47
Bus SA, Van Netten JJ, Hinchliffe RJ et al (2020) IWGDF editorial board. Standards for the development and methodology of the 2019 international working group on the diabetic foot guidelines. Diabet Metab Res Rev. https://doi.org/10.1002/dmrr.3267
doi: 10.1002/dmrr.3267
Norgren L, Hiatt WR, Dormandy JA et al (2006) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. https://doi.org/10.1016/j.ejvs.2006.09.024
doi: 10.1016/j.ejvs.2006.09.024 pubmed: 17140820
Aiello A, Anichini R, Brocco E, Caravaggi C, Chiavetta A, Cioni R, Da Ros R, De Feo ME, Ferraresi R, Florio F, Gargiulo M, Galzerano G, Gandini R, Giurato L, Graziani L, Mancini L, Manzi M, Modugno P, Setacci C, Uccioli L; Italian Society of Diabetes; Italian Society of Radiology; Italian Society of Vascular Endovascular Surgery. Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE). Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):355-69. doi: https://doi.org/10.1016/j.numecd.2013.12.007 . Epub 2013 Dec 25. PMID: 24486336
Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The Eurodiale Study Diabetologia 51(5):747–755
doi: 10.1007/s00125-008-0940-0
Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, Kono S, Lavery LA, Malone M, van Asten SA, Urbančič-Rovan V, Peters EJG (2020) International working group on the diabetic foot (IWGDF). Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. Suppl 1:e3280. doi: https://doi.org/10.1002/dmrr.3280 . PMID: 32176444
Mutluoglu M, Sivrioglu AK, Eroglu M, Uzun G, Turhan V, Ay H, Lipsky BA (2013) The implications of the presence of osteomyelitis on outcomes of infected diabetic foot wounds. Scand J Infect Dis 45(7):497–503. https://doi.org/10.3109/00365548.2013.765589
doi: 10.3109/00365548.2013.765589 pubmed: 23384323
Aragón-Sánchez FJ, Cabrera-Galván JJ, Quintana-Marrero Y, Hernández-Herrero MJ, Lázaro-Martínez JL, García-Morales E, Beneit-Montesinos JV, Armstrong DG (2008) Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetologia 51(11):1962–1970. https://doi.org/10.1007/s00125-008-1131-8
doi: 10.1007/s00125-008-1131-8 pubmed: 18719880
Lázaro Martínez JL, García Álvarez Y, Tardáguila-García A, García ME (2019) Optimal management of diabetic foot osteomyelitis: challenges and solutions. Diabetes Metab Syndr Obes 21(12):947–959. https://doi.org/10.2147/DMSO.S181198
doi: 10.2147/DMSO.S181198
Wise J (2016) Early referral for foot ulcers is vital, finds audit of diabetes care. BMJ 352:i1820. https://doi.org/10.1136/bmj.i1820
doi: 10.1136/bmj.i1820 pubmed: 27034450
Smith-Strøm H, Iversen MM, Igland J, Østbye T, Graue M, Skeie S, Wu B, Rokne B (2017) Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: a retrospective cohort study. PLoS ONE 12(5):e0177176. https://doi.org/10.1371/journal.pone.0177176.PMID:28498862;PMCID:PMC5428931
doi: 10.1371/journal.pone.0177176.PMID:28498862;PMCID:PMC5428931 pubmed: 28498862 pmcid: 5428931
Faglia E, Clerici G, Caminiti M, Quarantiello A, Gino M, Morabito A (2006) The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes. J Foot Ankle Surg. https://doi.org/10.1053/j.jfas.2006.04.002
doi: 10.1053/j.jfas.2006.04.002 pubmed: 16818148
Faglia E, Clerici G, Clerissi J, Gabrielli L, Losa S, Mantero M, Caminiti M, Curci V, Quarantiello A, Lupattelli T, Morabito A (2009) Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care. 2009 May;32(5):822–7. doi: https://doi.org/10.2337/dc08-1223 . Epub 2009 Feb 17. Erratum in: Diabetes Care. Jul;32(7):1355. Luppattelli, Tommaso [corrected to Lupattelli, Tommaso]. PMID: 19223609; PMCID: PMC2671089
Meloni M, Izzo V, Giurato L, Cervelli V, Gandini R, Uccioli L (2018) Impact of heart failure and dialysis in the prognosis of diabetic patients with ischemic foot ulcers. J Clin Transl Endocrinol 2(11):31–35. https://doi.org/10.1016/j.jcte.2018.01.002
doi: 10.1016/j.jcte.2018.01.002
Apelqvist J, Elgzyri T, Larsson J, Löndahl M, Nyberg P, Thörne J (2011) Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients. J Vasc Surg 53(6):1582–8.e2. https://doi.org/10.1016/j.jvs.2011.02.006
doi: 10.1016/j.jvs.2011.02.006 pubmed: 21515021
Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M, Apelqvist J (2009) Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 52(3):398–407. https://doi.org/10.1007/s00125-008-1226-2
doi: 10.1007/s00125-008-1226-2 pubmed: 19037626
Meloni M, Giurato L, Izzo V, Stefanini M, Pampana E, Gandini R, Uccioli L (2016) Long term outcomes of diabetic haemodialysis patients with critical limb ischemia and foot ulcer. Diabet Res Clin Pract 116:117–122. https://doi.org/10.1016/j.diabres.2016.04.030 (Epub 2016 Apr 26 PMID: 27321326)
doi: 10.1016/j.diabres.2016.04.030
Caruso P, Longo M, Signoriello S, Gicchino M, Maiorino MI, Bellastella G, Chiodini P, Giugliano D, Esposito K (2020) Diabetic foot problems during the COVID-19 pandemic in a tertiary care center: the emergency among the emergencies. Diabet Care 43(10):e123–e124. https://doi.org/10.2337/dc20-1347
doi: 10.2337/dc20-1347

Auteurs

Marco Meloni (M)

Diabetic Foot Unit, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy. meloni.marco@libero.it.

Jose Luis Lazaro-Martínez (JL)

Diabetic Foot Unit, Universidad Complutense de Madrid, Madrid, Spain.

Raju Ahluwalia (R)

Department of Trauma and Ortophaedic Department, King ́s College Hospital, London, UK.

Benjamin Bouillet (B)

Endocrinology Department, University Hospital Center, Dijon, France.

Valentina Izzo (V)

Diabetic Foot Unit, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.

Michela Di Venanzio (M)

UOSD Diabetologia San Camillo De Lellis Hospital, Rieti, Italy.

Elisabetta Iacopi (E)

Diabetic Foot Section, University of Pisa, Ospedale Di Cisanello, Pisa, Italy.

Chris Manu (C)

Diabetic Foot Clinic, King's College Hospital, Denmark Hill, London, UK.

José Luis Garcia-Klepzig (JL)

Internal Medicine Department, Hospital Clinico San Carlos De Madrid, Madrid, Spain.

Juan Pedro Sánchez-Ríos (JP)

Diabetic Foot Unit, Vascular Surgery Department, Hospital Fundación Alcorcón, Madrid, Spain.

Claas Lüedemann (C)

Franziskus Krankenhaus, Berlin, Germany.

Víctor Rodriguez-Saenz De Buruaga (VR)

Vascular Surgery Department, Donostia Hospital Universitario San Sebastian, San Sebastian, Spain.

Julien Vouillarmet (J)

Endocrinology Department, University Hospital Center, Lyon, France.

Jérôme Guillaumat (J)

University Hospital of Caen, Caen, France.

Anna Rita Aleandri (AR)

UOSD Diabetologia San Camillo De Lellis Hospital, Rieti, Italy.

Laura Giurato (L)

Diabetic Foot Unit, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.

Micheal Edmonds (M)

Diabetic Foot Clinic, King's College Hospital, Denmark Hill, London, UK.

Alberto Piaggesi (A)

Diabetic Foot Section, University of Pisa, Ospedale Di Cisanello, Pisa, Italy.

Kristien Van Acker (K)

Department of Endocrinology, Familie Ziekenhuis, Chimay, Belgium.

Luigi Uccioli (L)

Diabetic Foot Unit, University of Rome Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH